+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Colorectal Cancer"

Oncologists Global Market Opportunities and Strategies to 2032 - Product Thumbnail Image

Oncologists Global Market Opportunities and Strategies to 2032

  • Report
  • January 2024
  • 257 Pages
  • Global
From
From
From
Cancer Cachexia Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Cancer Cachexia Market - Forecasts from 2024 to 2029

  • Report
  • January 2024
  • 145 Pages
  • Global
From
From
From
Oncology Market in India 2025-2029 - Product Thumbnail Image

Oncology Market in India 2025-2029

  • Report
  • February 2025
  • 178 Pages
  • India
From
From
From
From
From
From
From
From
From
Radiation Oncology Market Report and Forecast 2023-2031 - Product Thumbnail Image

Radiation Oncology Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 147 Pages
  • Global
From
Loading Indicator

Colorectal cancer is a type of cancer that affects the colon and rectum. It is the third most common type of cancer in the world and is the second leading cause of cancer-related deaths in the United States. Treatment for colorectal cancer typically involves surgery, chemotherapy, and radiation therapy. In recent years, targeted therapies and immunotherapies have been developed to treat colorectal cancer. The oncology market for colorectal cancer is highly competitive, with a number of companies offering treatments and therapies. These include pharmaceutical companies such as Merck, Bristol-Myers Squibb, and Roche, as well as biotechnology companies such as ImmunoGen, Exelixis, and Incyte. Additionally, medical device companies such as Medtronic and Boston Scientific are involved in the development of treatments for colorectal cancer. Show Less Read more